von der Ohe J - Search Results

1

Autocrine growth regulation of human glomerular mesangial cells is primarily mediated by basic fibroblast growth factor.

Francki A, Uciechowski P, Floege J, von der Ohe J, Resch K, Radeke HH. Francki A, et al. Among authors: von der ohe j. Am J Pathol. 1995 Nov;147(5):1372-82. Am J Pathol. 1995. PMID: 7485400 Free PMC article.

2

Modulation of glomerular mesangial cell growth and prostaglandin release by T-lymphocyte products.

Radeke HH, Schwinzer B, von der Ohe J, Bovenkerk C, Resch K. Radeke HH, et al. Among authors: von der ohe j. Agents Actions. 1991 Jan;32(1-2):109-11. doi: 10.1007/BF01983331. Agents Actions. 1991. PMID: 1829315 No abstract available.

3

Activation of autoreactive T-lymphocytes by cultured syngeneic glomerular mesangial cells.

Radeke HH, Emmendörffer A, Uciechowski P, von der Ohe J, Schwinzer B, Resch K. Radeke HH, et al. Among authors: von der ohe j. Kidney Int. 1994 Mar;45(3):763-74. doi: 10.1038/ki.1994.101. Kidney Int. 1994. PMID: 8196277

4

Interleukin 1 activates jun N-terminal kinases JNK1 and JNK2 but not extracellular regulated MAP kinase (ERK) in human glomerular mesangial cells.

Uciechowski P, Saklatvala J, von der Ohe J, Resch K, Szamel M, Kracht M. Uciechowski P, et al. Among authors: von der ohe j. FEBS Lett. 1996 Oct 7;394(3):273-8. doi: 10.1016/0014-5793(96)00967-2. FEBS Lett. 1996. PMID: 8830657

5

c-Jun controls histone modifications, NF-kappaB recruitment, and RNA polymerase II function to activate the ccl2 gene.

Wolter S, Doerrie A, Weber A, Schneider H, Hoffmann E, von der Ohe J, Bakiri L, Wagner EF, Resch K, Kracht M. Wolter S, et al. Among authors: von der ohe j. Mol Cell Biol. 2008 Jul;28(13):4407-23. doi: 10.1128/MCB.00535-07. Epub 2008 Apr 28. Mol Cell Biol. 2008. PMID: 18443042 Free PMC article.

6

c-Met inhibitors attenuate tumor growth of small cell hypercalcemic ovarian carcinoma (SCCOHT) populations.

Otte A, Rauprich F, von der Ohe J, Yang Y, Kommoss F, Feuerhake F, Hillemanns P, Hass R. Otte A, et al. Among authors: von der ohe j. Oncotarget. 2015 Oct 13;6(31):31640-58. doi: 10.18632/oncotarget.5151. Oncotarget. 2015. PMID: 26436697 Free PMC article.

7

In Vitro Fusion of Normal and Neoplastic Breast Epithelial Cells with Human Mesenchymal Stroma/Stem Cells Partially Involves Tumor Necrosis Factor Receptor Signaling.

Melzer C, von der Ohe J, Hass R. Melzer C, et al. Among authors: von der ohe j. Stem Cells. 2018 Jul;36(7):977-989. doi: 10.1002/stem.2819. Epub 2018 Mar 28. Stem Cells. 2018. PMID: 29569804

8

Impaired P2X and P2Y receptor-mediated signaling in HPRT-deficient B103 neuroblastoma cells.

Erdorf M, von der Ohe J, Seifert R. Erdorf M, et al. Among authors: von der ohe j. Neurosci Lett. 2011 Oct 31;504(3):311-5. doi: 10.1016/j.neulet.2011.09.054. Epub 2011 Oct 1. Neurosci Lett. 2011. PMID: 21982803

9

SCCOHT tumors acquire chemoresistance and protection by interacting mesenchymal stroma/stem cells within the tumor microenvironment.

Otte A, Yang Y, von der Ohe J, Melzer C, Hillemanns P, Feuerhake F, Hass R. Otte A, et al. Among authors: von der ohe j. Int J Oncol. 2016 Dec;49(6):2453-2463. doi: 10.3892/ijo.2016.3735. Epub 2016 Oct 14. Int J Oncol. 2016. PMID: 27748897

10

Cancer stem cell niche models and contribution by mesenchymal stroma/stem cells.

Melzer C, von der Ohe J, Lehnert H, Ungefroren H, Hass R. Melzer C, et al. Among authors: von der ohe j. Mol Cancer. 2017 Feb 1;16(1):28. doi: 10.1186/s12943-017-0595-x. Mol Cancer. 2017. PMID: 28148265 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results